We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Helen of Troy's Oxo Brand to Develop New Injection Device
Read MoreHide Full Article
Consumer products company Helen of Troy Limited (HELE - Free Report) is all set to boost its presence in the health and wellness business. As a part of this strategy, Helen of Troy’s brand Oxo in partnership with Brussels, Belgium-based biopharmaceutical company UCB, develop new certolizumab pegol (Cimzia) AutoClicks Prefilled Pen in the National Health Services (NHS), UK.
These prefilled pens can be administered to cure diseases like rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis and axial spondyloarthritis. The validation for the use of these pens as injections was given by the European Medicine's Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).
The injections are extremely user-friendly and are specially designed keeping the hand disability of the patients in mind. Further, these feature a wide grip and a button-free delivery system that is beneficial for the patients. It has a large viewing window which enables patients to know about the start and the completion of the injection simply with double clicks. This ensures patients get the full dose of their medicine. The injections come at a monthly £715 (2 treatments doses of 200mg) for a patient.
Oxo brand, taken over by Helen of Troy in 2004, forms a part of the latter’s Housewares segment. Oxo’s products include kitchen tools, cutlery, bar and wine accessories as well as household cleaning tools, food storage containers and tea kettles. It products also include trash cans, storage and organization products, hand tools, gardening tools, kitchen mitts and trivets, barbecue tools and baby and toddler care products. The OXO brand is widely known for its user-friendly consumer products.
Recently, in Mar 2016, Helen of Troy reinforced its Housewares segment by the takeover of the brand Hydro Flask and all membership units of Steel Technology, LLC in a cash deal worth $210 million. Apart from this, the company took over the Vicks Vaposteam business from the Procter & Gamble Company (PG - Free Report) in Mar 2015 following its venture into vitamin supplements space with the Healthy Directions buyout in 2014.
Zacks Rank
Helen of Troy carries a Zacks Rank #4 (Sell).
Better ranked stocks in the cosmetics and toiletries sector include Avon Products Inc. and Nu Skin Enterprises Inc. (NUS - Free Report) .
Nu Skin Enterprises Inc. carries a Zacks Rank #2 (Buy) and has a long-term growth rate of 7.8%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Helen of Troy's Oxo Brand to Develop New Injection Device
Consumer products company Helen of Troy Limited (HELE - Free Report) is all set to boost its presence in the health and wellness business. As a part of this strategy, Helen of Troy’s brand Oxo in partnership with Brussels, Belgium-based biopharmaceutical company UCB, develop new certolizumab pegol (Cimzia) AutoClicks Prefilled Pen in the National Health Services (NHS), UK.
These prefilled pens can be administered to cure diseases like rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis and axial spondyloarthritis. The validation for the use of these pens as injections was given by the European Medicine's Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).
The injections are extremely user-friendly and are specially designed keeping the hand disability of the patients in mind. Further, these feature a wide grip and a button-free delivery system that is beneficial for the patients. It has a large viewing window which enables patients to know about the start and the completion of the injection simply with double clicks. This ensures patients get the full dose of their medicine. The injections come at a monthly £715 (2 treatments doses of 200mg) for a patient.
HELEN OF TROY Price
HELEN OF TROY Price | HELEN OF TROY Quote
Oxo brand, taken over by Helen of Troy in 2004, forms a part of the latter’s Housewares segment. Oxo’s products include kitchen tools, cutlery, bar and wine accessories as well as household cleaning tools, food storage containers and tea kettles. It products also include trash cans, storage and organization products, hand tools, gardening tools, kitchen mitts and trivets, barbecue tools and baby and toddler care products. The OXO brand is widely known for its user-friendly consumer products.
Recently, in Mar 2016, Helen of Troy reinforced its Housewares segment by the takeover of the brand Hydro Flask and all membership units of Steel Technology, LLC in a cash deal worth $210 million. Apart from this, the company took over the Vicks Vaposteam business from the Procter & Gamble Company (PG - Free Report) in Mar 2015 following its venture into vitamin supplements space with the Healthy Directions buyout in 2014.
Zacks Rank
Helen of Troy carries a Zacks Rank #4 (Sell).
Better ranked stocks in the cosmetics and toiletries sector include Avon Products Inc. and Nu Skin Enterprises Inc. (NUS - Free Report) .
Avon Products Inc. carries a Zacls Rank #1 (Strong Buy) and carries a long term growth rate of 5%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nu Skin Enterprises Inc. carries a Zacks Rank #2 (Buy) and has a long-term growth rate of 7.8%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>